Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Pulmonology
  • Pulmonology News
  • Bilastine and...

Bilastine and Montelukast combo safe and effective for Allergic Rhinitis patients

AditiWritten by Aditi Published On 2023-05-23T10:15:12+05:30  |  Updated On 23 May 2023 6:16 AM GMT
Bilastine and Montelukast combo safe and effective for Allergic Rhinitis patients
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • koo
  • Email

India: A study published in the Journal of Asthma by Shubhadeep D Sinha and the team has provided information on the excellent tolerability of a combo of Bilastine 20mg and Montelukast 10mg in patients with Allergic rhinitis.Explaining research background, they said that in AR, Histamine and cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators. Additional benefits can be...

India: A study published in the Journal of Asthma by Shubhadeep D Sinha and the team has provided information on the excellent tolerability of a combo of Bilastine 20mg and Montelukast 10mg in patients with Allergic rhinitis.

Explaining research background, they said that in AR, Histamine and cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators. Additional benefits can be obtained using combination therapy against these potent inflammatory mediators.

Previous researchers have mentioned that using Levocetirizine and highly selective leukotriene receptor antagonists like Montelukast are widely prescribed in combination due to the additional benefits of this combination in AR patients.

The Indian study evaluated the efficacy and safety of Bilastine 20mg and Montelukast 10mg fixed drug combination at 16 ENT centres.

Important study points are:

  • The study included Adult patients with AR for at least one year with positive IgE antibody test and 12-hour NSS score > 36 during the last three days.
  • The patients were randomized to receive either a fixed-dose combination or FDC of Bilastine 20 mg & Montelukast 10 mg or FDC Montelukast 10 mg & Levocetirizine 5 mg tablets for four weeks.
  • The primary endpoints measured was change in mean total symptom score (nasal symptom scores (NSS) & non-nasal symptom scores (NNSS)) (baseline to week 4).
  • The change in mean TSS was 16.6 units in Bilastine 20mg and Montelukast 10mg FDC compared to 17 units in Levocetirizine 5mg and Montelukast 10mg FDC.
  • There was a comparable difference in mean change between groups.

The study addressed the combination of Bilastine 20mg and Montelukast 10mg in allergic rhinitis patients.

They also said that the combination was well tolerated in such patients

Further reading:

Sinha SD, Perapogu S, Chary SS, Ramesh H, Bakshi J, Singh A, Ahmed AK, Mohan Reddy B, Panapakam M, Talluri L, Vattipalli R. Efficacy and Safety of Fixed-Dose Combination of Bilastine in Adult Patients with Allergic Rhinitis: A Phase III, Randomized, Multi-Center, Double-Blind, Active Controlled Clinical Study. J Asthma. 2023 May 4:1-9. doi: 10.1080/02770903.2023.2209175.

allergic rhinitisJournal of AsthmaBilastine 20 mgmontelukast 10 mg
Source : Journal of Asthma
Aditi
Aditi

    BDS,MDS in Periodontics and Implantology

    Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.

    Show Full Article

    More News

    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X